shutterstock_313478648

The U.S. Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals' CTEXLI (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous...

FibroGen has sold its China subsidiary to AstraZeneca for approximately $160 million. Thane Wettig, Chief Executive Officer of FibroGen, said: “Today, we announced the sale...

Pharmanovia has signed an exclusive distribution agreement with Er-Kim, to enhance the availability of Sunosi (Solriamfetol), a first-in-class treatment for Excessive Daytime Sleepiness (EDS),...